The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer-Reference-Cited by-同舟云学术

The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer

Published:2024-09-12 Issue: Volume: Page:
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Guo Shikuan,Ren Jing,Meng Qingze,Zhang Boyuan,Jiao Jianhua,Han Donghui,Wu Peng,Ma Shuaijun,Zhang Jing,Xing Nianzeng,Qin Weijun^ORCID,Kang Fei,Zhang Jingliang^ORCID

Funder

National Natural Science Foundation of China

Clinical Research Project of Fourth Military Medical University

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00259-024-06916-2.pdf

Reference31 articles.

1. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024.

2. Drost FH, Osses DF, Nieboer D, Steyerberg EW, Bangma CH, Roobol MJ, et al. Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019;4:CD012663.

3. Westphalen AC, McCulloch CE, Anaokar JM, Arora S, Barashi NS, Barentsz JO, et al. Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate Cancer Disease-focused panel. Radiology. 2020;296:76–84.

4. Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, et al. Intra- and interreader reproducibility of PI-RADSv2: a multireader study. J Magn Reson Imaging. 2019;49:1694–703.

5. Alberts AR, Roobol MJ, Verbeek JFM, Schoots IG, Chiu PK, Osses DF, et al. Prediction of high-grade prostate Cancer following multiparametric magnetic resonance imaging: improving the Rotterdam European Randomized Study of screening for prostate Cancer risk calculators. Eur Urol. 2019;75:310–8.